HOPMAN MARK (Chief Commercial Officer) sold 29.7% of their position (36.87K shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $680.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/10/2026ACC: 0002048497-26-000013
Officer· Chief Commercial Officer
Since Mar 2026
-36.87K
Net shares
Net seller
$680.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
36.87K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−36.87K
Price / share
$18.46
Trade value
$680.72K
% of position
29.7%
9/9/2026
124.03K→87.16K
Total
Net shares
−36.87K
Net value
-$680.72K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/9/2026 | S · Sale | −36.87K | $18.46 | $680.72K | 29.7% | 124.03K | 87.16K |
| Total | −36.87K | -$680.72K | ||||||
Derivative Transactions0
No derivative transactions reported